Monoamine oxidases: to inhibit or not to inhibit.

R. R. Ramsay*, M. B. Gravestock

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

40 Citations (Scopus)


Monoamine oxidase (MAO) inhibitors were developed as antidepressants but many drugs, including the novel oxazolidinone antibacterial agents, share similar molecular properties and have MAO inhibitory activity. Factors important for binding antidepressants and modifications to decrease binding of oxazolidinones to avoid undesirable vascular effects are discussed.

Original languageEnglish
Pages (from-to)129-136
Number of pages8
JournalMini reviews in medicinal chemistry
Issue number2
Publication statusPublished - 1 Jan 2003


Dive into the research topics of 'Monoamine oxidases: to inhibit or not to inhibit.'. Together they form a unique fingerprint.

Cite this